Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sting Therapeutics
Singapore, Singaporestingtherapeutics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Sting Therapeutics is a Singapore-based biotechnology company dedicated to advancing cancer immunotherapy through the modulation of the STING (Stimulator of Interferon Genes) pathway. The company is developing a pipeline of novel, small-molecule STING agonists designed to overcome the pharmacological hurdles of earlier-generation candidates, such as poor bioavailability and rapid clearance. By selectively activating the innate immune system within the tumor microenvironment, Sting Therapeutics aims to turn cold tumors hot and improve outcomes for patients with various solid tumors. Their approach leverages deep expertise in immunology and medicinal chemistry to create systemic and intratumoral therapies.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Agency for Science, Technology and Research (A*STAR)
Beyond the preview
Go deeper on Sting Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sting Therapeutics.